<body><a name="drugname"></a><table class="topbox" width="100%">
<tr>
<td><span class="topboxgenname">CALCIUM GLUCONATE <img border="0" src="../images/pr.gif"/></span><br/>(gloo'koe-nate)<br/><span class="topboxtradename">Kalcinate<br/></span><b>Classifications:</b> <span class="classification">fluid and electrolytic and water balance agent</span>; <span class="classification">replacement solution</span><br/><b>Pregnancy Category: </b>B<br/></td>
</tr>
</table>
<h1><a name="avail">Availability</a></h1>
<p>500 mg, 650 mg, 975 mg, 1 gm tablets; 10% injection</p>
<h1><a name="action">Actions</a></h1>
<p>Calcium is an essential element for regulating the excitation threshold of nerves and muscles, for blood clotting mechanisms,
         cardiac function (rhythm, tonicity, contractility), maintenance of renal function, for body skeleton and teeth. Also plays
         a role in regulating storage and release of neurotransmitters and hormones; regulating amino acid uptake and absorption of
         vitamin B<sub>12</sub>, gastrin secretion, and in maintaining structural and functional integrity of cell membranes and capillaries. Calcium gluconate
         acts like digitalis on the heart, increasing cardiac muscle tone and force of systolic contractions (positive inotropic effect).
      </p>
<h1><a name="therapef">Therapeutic Effects</a></h1>
<p>Rapidly and effectively restores serum calcium levels in acute hypocalcemia of various origins and effective cardiac stabilizer
         under conditions of hyperkalemia or resuscitation.
      </p>
<h1><a name="uses">Uses</a></h1>
<p>Negative calcium balance (as in neonatal tetany, hypoparathyroidism, vitamin D deficiency, alkalosis). Also to overcome cardiac
         toxicity of hyperkalemia, for cardiopulmonary resuscitation, to prevent hypocalcemia during transfusion of citrated blood.
         Also as antidote for magnesium sulfate, for acute symptoms of lead colic, to decrease capillary permeability in sensitivity
         reactions, and to relieve muscle cramps from insect bites or stings. Oral calcium may be used to maintain normal calcium balance
         during pregnancy, lactation, and childhood growth and to prevent primary osteoporosis. Also in osteoporosis, osteomalacia,
         chronic hypoparathyroidism, rickets, and as adjunct in treatment of myasthenia gravis and Eaton-Lambert syndrome.
      </p>
<h1><a name="unlabeleduses">Unlabeled Uses</a></h1>
<p>To antagonize aminoglycoside-induced neuromuscular blockage, and as "calcium challenge" to diagnose Zollinger-Ellison
         syndrome and medullary thyroid carcinoma.
      </p>
<h1><a name="contrain">Contraindications</a></h1>
<p>Ventricular fibrillation, metastatic bone disease, injection into myocardium; administration by SC or IM routes; renal calculi,
         hypercalcemia, predisposition to hypercalcemia (hyperparathyroidism, certain malignancies); pregnancy (category B).
      </p>
<h1><a name="precaution">Cautious Use</a></h1>
<p>Digitalized patients, renal or cardiac insufficiency, sarcoidosis, history of lithiasis, immobilized patients; lactation.</p>
<h1><a name="rtedsg">Route &amp; Dosage</a></h1>
<table cellpadding="4" cellspacing="0" class="rdbox" width="100%">
<tr>
<td>
<p>
<b>All doses are in terms of <i>elemental calcium:</i> 1 g calcium gluconate = 90 mg (4.5 mEq, 9.3%) elemental calcium</b>
</p><span class="indicationtitle">Supplement for Osteoporosis</span><br/><span class="rdage">Adult:</span> <span class="rdroute">PO</span> 12 g b.i.d. to q.i.d. <span class="rdroute">IV</span> 7 mEq q13d<br/><span class="rdage">Child:</span> <span class="rdroute">PO</span> 4565 mg/kg/d in divided doses. <span class="rdroute">IV</span> 17 mEq q13d<br/><span class="rdage">Neonate:</span> <span class="rdroute">PO</span> 50130 mg/kg/d (max: 1 g) <span class="rdroute">IV</span> mEq q13d<br/><br/><span class="indicationtitle">Hypocalcemic Tetany</span><br/><span class="rdage">Adult:</span> <span class="rdroute">IV</span> 4.516 mEq prn<br/><span class="rdage">Child:</span> <span class="rdroute">IV</span> 0.50.7 mEq/kg t.i.d. or q.i.d.<br/><span class="rdage">Neonate:</span> <span class="rdroute">IV</span> 2.4 mEq/kg/d in divided doses<br/><br/><span class="indicationtitle">CPR</span><br/><span class="rdage">Adult:</span> <span class="rdroute">IV</span> 2.33.7 mEq x 1<br/><br/><span class="indicationtitle">Hyperkalemia with Cardiac Toxicity</span><br/><span class="rdage">Adult:</span> <span class="rdroute">IV</span> 2.2514 mEq q 12 min<br/><br/><span class="indicationtitle">Exchange Transfusions with Citrated Blood</span><br/><span class="rdage">Adult:</span> <span class="rdroute">IV</span> 1.35 mEq for each 100 mL of blood<br/><span class="rdage">Neonate:</span> <span class="rdroute">IV</span> 0.45 mEq for each 100 mL of blood<br/></td>
</tr>
</table>
<h1><a name="admintn">Administration</a></h1><span class="adminroutetype">Oral</span><br/><ul>
<li>Ensure that chewable tablets are chewed or crushed before being swallowed with a liquid.</li>
<li>Give with meals to enhance absorption.</li>
</ul>
<table cellpadding="4" cellspacing="0" class="ivbox" width="100%">
<tr>
<td><span class="ivtitle">Intravenous</span><p><span class="routemethod">PREPARE:</span> <span class="methodtype"> Direct:</span> May be given undiluted   <span class="methodtype">Intermittent/Continuous:</span> May be diluted in 1000 mL of NS.  
               </p>
<p><span class="routemethod">ADMINISTER:</span> <span class="methodtype"> Direct:</span> Give direct IV at a rate of 0.5 mL or a fraction thereof over 1 min. Do not exceed 2 mL/min.   <span class="methodtype">Intermittent/Continuous:</span> Give slowly, not to exceed 200 mg/min, through a small-bore needle into a large vein to avoid possibility of extravasation
                  and resultant necrosis. With children, scalp veins should be avoided. Avoid rapid infusion. High concentrations of calcium
                  suddenly reaching the heart can cause fatal cardiac arrest.  
               </p>
<p><span class="routemethod">INCOMPATIBILITIES</span> <span class="incompattype"> Solution/additive:</span>
<b>Amphotericin B,</b>
<b>cefamandole,</b>
<b>dobutamine,</b>
<b>methylprednisolone,</b>
<b>metoclopramide</b>, concentration-dependent incompatibility with other <span class="classification">electrolytes.</span>
<span class="incompattype">Y-site:</span>
<b>Amphotericin B cholesteryl complex,</b>
<b>fluconazole,</b>
<b>indomethacin.</b>
</p>
<ul>
<li>Injection should be stopped if patient complains of any discomfort.</li>
<li> Patient should be advised to remain in bed for 1530 min or more following injection, depending on response.</li>
</ul>
</td>
</tr>
</table>
<h1><a name="adverse">Adverse Effects (<img src="../images/special/greaterorequal.gif"/>1%)</a></h1><span class="typehead">Body as a Whole:</span> Tingling sensation. With rapid IV, sensations of heat waves (peripheral vasodilation), fainting. <span class="typehead">GI:</span> PO preparation: Constipation, increased gastric acid secretion. <span class="typehead">CV:</span> (With rapid infusion) hypotension, bradycardia, cardiac arrhythmias, <span class="speceff-life">cardiac arrest</span>, <span class="typehead">Skin:</span> Pain and burning at IV site, severe venous thrombosis, necrosis and sloughing (with extravasation). 
      <h1><a name="dtintefer">Diagnostic Test Interference</a></h1>
<p>IV calcium may cause false decreases in <span class="alt">serum and urine magnesium</span> (by <span class="alt">Titan yellow method</span>) and transient elevations of <span class="alt">plasma 11-OHCS</span> levels by <span class="alt">Glenn-Nelson technique.</span> Values usually return to control levels after 60 min; <span class="alt">urinary steroid values (17-OHCS)</span> may be decreased.
      </p>
<h1><a name="interactions">Interactions</a></h1><span class="typehead"> Drug:</span>  May enhance inotropic and toxic effects of <b>digoxin;</b>
<b>magnesium</b> may compete for GI absorption; decreases absorption of <span class="classification">tetracyclines</span>, <span class="classification">quinolones</span> (<b>ciprofloxacin</b>); antagonizes the effects of <b>verapamil</b> and possibly other <span class="classification">calcium channel blockers</span> (IV administration). 
      <h1><a name="pharmaks">Pharmacokinetics</a></h1><span class="typehead">Absorption:</span> Approximately <small>1/3</small> of dose absorbed from small intestine. <span class="typehead">Onset:</span> Immediately after IV. <span class="typehead">Distribution:</span> Crosses placenta. <span class="typehead">Elimination:</span> Primarily excreted in feces; small amounts excreted in urine, pancreatic juice, saliva, and breast milk. 
      <h1><a name="nursing"><span class="implictitle">Nursing Implications</span></a></h1>
<p><span class="adeffecttitle">Assessment &amp; Drug Effects</span></p>
<ul>
<li>Assess for cutaneous burning sensations and peripheral vasodilation, with moderate fall in BP, during direct IV injection.</li>
<li>Monitor ECG during IV administration to detect evidence of hypercalcemia: decreased QT interval associated with inverted T
            wave.
         </li>
<li>Observe IV site closely. Extravasation may result in tissue irritation and necrosis.</li>
<li>Monitor for hypocalcemia and hypercalcemia (see Signs &amp; Symptoms, Appendix F).</li>
<li>Lab tests: Determine levels of calcium and phosphorus (tend to vary inversely) and magnesium frequently, during sustained
            therapy. Deficiencies in other ions, particularly magnesium, frequently coexist with calcium ion depletion.
         </li>
</ul>
<p><span class="eductitle">Patient &amp; Family Education</span></p>
<ul>
<li>Report S&amp;S of hypercalcemia (see Appendix F) promptly to your care provider.</li>
<li>Milk and milk products are the best sources of calcium (and phosphorus). Other good sources include dark green vegetables,
            soy beans, tofu, and canned fish with bones.
         </li>
<li>Calcium absorption can be inhibited by zinc-rich foods: nuts, seeds, sprouts, legumes, soy products (tofu).</li>
<li>Check with physician before self-medicating with a calcium supplement.</li>
<li>Do not breast feed while taking this drug without consulting physician.</li>
</ul>
<hr/>
<p><span class="footer">Common adverse effects in <i>italic</i>, life-threatening effects <u>underlined</u>; generic names in <b>bold</b>; classifications in <small>SMALL CAPS</small>; <img border="0" src="../images/maple.gif"/> Canadian drug name; <img border="0" src="../images/pr.gif"/> Prototype drug</span></p>
</body>